Multiple eruptive dermatofibromas related to imatinib treatment

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 7, 2014, Pages 979-981

  Llamas Velasco, M ^a   Fraga, J ^a   Solano Lopez G E ^a   Steegmann, J L ^a   Garcia Diez A ^a   Requena, L ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Department of Pathology Hospital Universitario de la Princesa ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFALIZUMAB; IMATINIB; METHOTREXATE; NILOTINIB; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ACANTHOSIS; ADULT; ARM; AUTOIMMUNE DISEASE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DERMATOFIBROMA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; LEG; LETTER; MALE; MAST CELL; MELANOCYTE; MULTIPLE ERUPTIVE DERMATOFIBROMA; NEOPLASM; PRIORITY JOURNAL; SKIN BIOPSY; SKIN NODULE; TREATMENT FAILURE; TRUNK; BIOPSY; CHEMICALLY INDUCED; DRUG EFFECTS; HISTIOCYTOMA, BENIGN FIBROUS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; PATHOLOGY; SKIN; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BENZAMIDES; BIOPSY; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; SKIN; TREATMENT OUTCOME;

EID: 84905057976     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12328     Document Type: Letter

References (8)

1. Ammirati CT, Mann C, Hornstra IK,. Multiple eruptive dermatofibromas in three men with HIV infection. Dermatology 1997; 195: 344-348.
2. Tsunemi Y, Tada Y, Saeki H, Ihn H, Tamaki K,. Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjogren's syndrome. Clin Exp Dermatol 2004; 29: 483-485.
3. Huang PY, Chu CY, Hsiao CH,. Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate. J Am Acad Dermatol 2007; 57: S81-S84.
4. Santos-Juanes J, Coto-Segura P, Mallo S, Galache C, Soto J,. Multiple eruptive dermatofibromas in a patient receiving efalizumab. Dermatology 2008; 216: 363.
5. Bachmeyer C, Cordier F, Blum L, Cazier A, Verola O, Aractingi S,. Multiple eruptive dermatofibromas after highly active antiretroviral therapy. Br J Dermatol 2000; 143: 1336-1337.
6. Rojas JM, Wang L, Owen S, Knight K, Watmough SJ, Clark RE,. Naturally occurring CD4+ CD25+ FOXP3+ T-regulatory cells are increased in chronic myeloid leukemia patients not in complete cytogenetic remission and can be immunosuppressive. Exp Hematol 2010; 38: 1209-1218.
7. Nestle FO, Nickoloff BJ, Burg G,. Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells? Dermatology 1995; 190: 265-268.
8. Alexandrescu DT, Wiernik PH,. Multiple eruptive dermatofibromas occurring in a patient with chronic myelogenous leukemia. Arch Dermatol 2005; 141: 397-398.